Healthy.io

Healthy.io

A technology company making urine analysis kits for detecting Chronic Kidney Disease (CKD), Urinary Track Infections (UTI), and prenatal pregnancy complication monitoring.

Healthy.io is a technology company making urine analysis kits for detecting Chronic Kidney Disease (CKD), Urinary Track Infections (UTI), and prenatal pregnancy complication monitoring that is headquartered in Tel Aviv, Israel and was founded in 2013 by Yonatan Adiri. The companies urine analysis kits are paired with a smart phone application that allows users to view their results through viewing their personal electronic medical record.

Funding

Series B

On February 5, 2019 Healthy.io completed their series B funding round with $18 million in funding from Aleph (lead investor), Samsung NEXT, and private investors. The company plans on using the funding to expand its operations in the United States and the United Kingdom.

Series C

On September 30, 2019 Healthy.io completed their series C funding round with $60 million in funding from Corner Ventures (lead investor), Joy Capital, Ansonia Holdings, Aleph, and Samsung NEXT. The company plans on using their series C funding to increase its global operations and to work on further developing their products.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Healthy.io funding round, September 2019
Series C round
60,000,000
September 2019
Aleph
Healthy.io funding round, October 2019
Series C round
60,000,000
October 2019
Corner Ventures
Healthy.io funding round, February 2019
Series B round
18,000,000
February 2019
Aleph
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.